Palom Adriana, Rando-Segura Ariadna, Vico Judit, Pacín Beatriz, Vargas Elena, Barreira-Díaz Ana, Rodríguez-Frías Francisco, Riveiro-Barciela Mar, Esteban Rafael, Buti Maria
Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
JHEP Rep. 2022 Jul 21;4(10):100547. doi: 10.1016/j.jhepr.2022.100547. eCollection 2022 Oct.
BACKGROUND & AIMS: Although EASL guidelines recommend anti-HDV testing in all HBsAg-positive individuals, HDV infection remains an underdiagnosed condition. We describe the impact of an HDV screening program by reflex anti-HDV testing in all HBsAg-positive samples and compare the results before and after its implementation.
In total, 2,236 HBsAg-positive determinations were included from January 2018 to December 2021. Only the first sample from each participant was evaluated: 1,492 samples before reflex anti-HDV testing (2018-2020) and 744 samples after (2021). Demographic and clinical characteristics of anti-HDV-positive patients were collected.
Before reflex testing, anti-HDV had been tested in 7.6% (114/1492) of HBsAg-positive individuals: 23% (91/390) attended in an academic hospital and only 2% (23/1,102) in primary care centres. After reflex testing was established, 93% (691/744) of HBsAg-positive cases were evaluated for anti-HDV: 91% (533/586) in the academic hospital and 100% (158/158) in primary care. The anti-HDV-positive prevalence was similar before and after reflex testing: 9.6% (11/114) and 8.1% (56/691), respectively. However, the absolute number of anti-HDV-positive patients increased. Most anti-HDV-positive patients were young, HBeAg-negative, Caucasian males. HDV-RNA was detectable in 35 (65%) of 54 tested, HBV-DNA was undetectable in 64%, and alanine aminotransferase levels were normal in 48%.
Anti-HDV reflex testing quintupled the absolute number of diagnoses of chronic hepatitis D infection. Before the reflex test, a large percentage of HBsAg-positive individuals had not undergone any anti-HDV determination. Implementation of reflex testing increases the diagnosis of patients with chronic hepatitis D.
Chronic hepatitis delta (CHD) is a viral disease caused by HDV, which requires the presence of HBV to propagate. HDV infection can cause rapid progression to cirrhosis, among other severe complications. The prevalence of CHD worldwide is controversial, and the infection often goes unrecognised, mainly because of unawareness among physicians. Use of reflex testing in other viral hepatitis has proven to increase detection and linking-to-care of infected patients. Implementation of anti-HDV testing in all HBsAg-positive patients has led to a 5-fold increase in the number of HDV diagnoses in an academic hospital and primary care centres.
尽管欧洲肝脏研究学会(EASL)指南建议对所有HBsAg阳性个体进行抗HDV检测,但HDV感染仍然是一种诊断不足的疾病。我们描述了通过对所有HBsAg阳性样本进行抗HDV反射检测的HDV筛查项目的影响,并比较了实施前后的结果。
2018年1月至2021年12月共纳入2236例HBsAg阳性检测结果。仅评估每位参与者的首个样本:抗HDV反射检测前(2018 - 2020年)有1492个样本,之后(2021年)有744个样本。收集抗HDV阳性患者的人口统计学和临床特征。
在反射检测前,7.6%(114/1492)的HBsAg阳性个体进行了抗HDV检测:23%(91/390)在学术医院进行检测,而在基层医疗中心仅为2%(23/1102)。建立反射检测后,93%(691/744)的HBsAg阳性病例进行了抗HDV评估:在学术医院为91%(533/586),在基层医疗中心为100%(158/158)。反射检测前后抗HDV阳性患病率相似:分别为9.6%(11/114)和8.1%(56/691)。然而,抗HDV阳性患者的绝对数量增加了。大多数抗HDV阳性患者为年轻、HBeAg阴性的白种男性。54例检测者中有35例(65%)可检测到HDV - RNA,64%的患者HBV - DNA检测不到,48%的患者丙氨酸转氨酶水平正常。
抗HDV反射检测使慢性丁型肝炎感染的诊断绝对数量增加了五倍。在反射检测前,很大比例的HBsAg阳性个体未进行任何抗HDV检测。实施反射检测增加了慢性丁型肝炎患者的诊断。
慢性丁型肝炎(CHD)是一种由HDV引起的病毒性疾病,HDV需要HBV存在才能传播。HDV感染可导致快速进展为肝硬化以及其他严重并发症。全球CHD的患病率存在争议,且该感染常常未被识别,主要是因为医生对此认识不足。在其他病毒性肝炎中使用反射检测已被证明可增加对感染患者的检测和治疗衔接。对所有HBsAg阳性患者实施抗HDV检测已使学术医院和基层医疗中心的HDV诊断数量增加了5倍。